文献速递产科母胎医学

全基因组测序NIPT实验室方法及NIPTmer软件验证

[Not Available].
PubMed 文献 · Prenat Diagn · 2019-11-06

研究纳入424份孕妇血样,验证基于全基因组测序的NIPT实验室方法及NIPTmer染色体非整倍体检测软件,并评估将其整合至爱沙尼亚产前临床护理的潜力。NIPTmer以100%灵敏度正确识别所有非嵌合T21、T18、T13及单体X样本,但漏检一例嵌合T18,假阳性率为1.5%(6/398)。

要点

  • NIPTmer对非嵌合T21、T18、T13及单体X的灵敏度为100%。
  • 假阳性率1.5%(6/398),T18和T13特异性均为99.3%。
  • 一例嵌合T18未被检出,8例cffDNA<4%中2例仍判定为非整倍体。

核心结论

  • 研究者认为该NIPT方法可作为通用一线筛查试验,与早孕期超声检查联合使用。

研究设计与样本

  • 研究纳入424份孕妇血样,分析流程包括游离DNA提取、文库制备及Illumina平台大规模平行测序。
  • 非整倍体通过NIPTmer软件判定,该软件基于计数测序原始数据中预设的每染色体唯一k-mer集。
  • 采用SeqFF估计游离胎儿DNA(cffDNA)分数。

主要发现

  • NIPTmer以100%灵敏度正确识别所有非嵌合T21(15/15)、T18(9/9)、T13(4/4)及单体X(4/4)样本。
  • 一例嵌合T18未被检出。
  • 观察到6例假阳性结果,假阳性率为1.5%(6/398),其中T18三例(特异性99.3%)、T13三例(特异性99.3%)。
  • 8例样本cffDNA水平估计<4%,其中包括一例T13和一例T18样本;尽管cffDNA水平低,这两例样本仍被判定为非整倍体。

关键数值与推荐

  • NIPTmer对非嵌合T21、T18、T13及单体X的灵敏度为100%。
  • 假阳性率为1.5%(6/398),T18和T13的特异性均为99.3%。
  • 8例样本cffDNA水平<4%,其中一例T13和一例T18样本仍被判定为非整倍体。

临床怎么用

  • 该NIPT方法有潜力作为通用一线筛查试验,与早孕期超声检查联合用于胎儿检查。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study aimed to validate a whole-genome sequencing-based NIPT laboratory method and our recently developed NIPTmer aneuploidy detection software with the potential to integrate the pipeline into prenatal clinical care in Estonia. METHOD: In total, 424 maternal blood samples were included. Analysis pipeline involved cell-free DNA extraction, library preparation and massively parallel sequencing on Illumina platform. Aneuploidies were determined with NIPTmer software, which is based on counting pre-defined per-chromosome sets of unique k-mers from sequencing raw data. SeqFF was implemented to estimate cell-free fetal DNA (cffDNA) fraction. RESULTS: NIPTmer identified correctly all samples of non-mosaic trisomy 21 (T21, 15/15), T18 (9/9), T13 (4/4) and monosomy X (4/4) cases, with the 100% sensitivity. However, one mosaic T18 remained undetected. Six false-positive (FP) results were observed (FP rate of 1.5%, 6/398), including three for T18 (specificity 99.3%) and three for T13 (specificity 99.3%). The level of cffDNA of <4% was estimated in eight samples, including one sample with T13 and T18. Despite low cffDNA level, these two samples were determined as aneuploid. CONCLUSION: We believe that the developed NIPT method can successfully be used as a universal primary screening test in combination with ultrasound scan for the first trimester fetal examination.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Žilina O, Rekker K, Kaplinski L, et al. [Not Available]. Prenat Diagn. 2019. PMID: 31691324. doi:10.1002/pd.5578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。